In the present study, we collected serum from 10 primary HER2-positive BC cases receiving NAC at Hospital Universitario Lucus Augusti (HULA) with the experimental protocol approved by the Ethics Committee of this center. This evidence concerns the gene ERBB2 and breast cancer.